In this study, we performed a genome-wide CRISPR-Cas9 loss-of-function screening and identified CREBBP as a vulnerability specific to the ABC-like DLBCL cell line RC-K8, which harboured a translocation that disrupts the EP300 gene. This evidence concerns the gene CREBBP and diffuse large B-cell lymphoma.